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Abstract
Several techniques for surgical treatment of acute or subacute left ventricular free wall rupture (LVFWR) have been described using a
sutured or sutureless patch with different currently available materials. We present a case report of a 50-year-old male with acute LVFWR,
who was treated with a simple surgical technique using an ‘off-pump’ epicardially sutured LV patch consisting of an acellular xenogeneic
extracellular matrix (ECM). ECM patches are structurally more surgeon-friendly and have shown to be bioactive, and capable of activating
remodelling and even tissue regeneration. Compared with conventional pericardial patches, the advantage of this material is excellent pli-
ability and very easy stitching owing to the thin composition of the material. In addition, and most importantly, in case of complex struc-
tural reconstructions, the patch is highly tear-proof.
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INTRODUCTION
Since the advent of percutaneous coronary intervention (PCI) left
ventricular free wall rupture (LVFWR) is nowadays a very rare and
uncommon complication following acute transmural myocar-
dial infarction; however, LVFWR has very high mortality rates
(5–24% of all in-hospital deaths) due to both the severity of
disease and the complexity of surgical management. Although
the majority of patients die immediately after rupture, the
survivors basically present with three different courses of the
rupture: catastrophic ‘blow-out’, subacute ‘oozing’ and chronic
‘false aneurysm’ types.
Despite the few reports of percutaneous intrapericardial
ﬁbrin-glue injection therapy as a new treatment alternative for
cases with ‘oozing’ type LVFWR, emergency surgical repair is
considered the gold standard therapy. Several surgical techni-
ques have been described [1–3]; yet which technique and
material should be used still remains controversial. One
option is to treat the rupture with an epicardially sutured patch
in the beating heart without the use of cardiopulmonary
bypass. We report a simple technique for treatment of LVFWR
with an epicardially sutured LV patch using an acellular xeno-
geneic extracellular matrix (ECM) in order to identify a new ma-
terial, which would be more surgeon-friendly, biocompatible
and bioresorbable, and show remodelling and even tissue
regeneration [4, 5].
CASE PRESENTATION
A 50-year-old male was referred to our department, presenting
with cardiogenic shock due to the acute transmural myocardial in-
farction of the posterior wall, which was treated by PCI of the cir-
cumﬂex artery. Consequently, LVFWR was suspected and the
pericardium was drained with the pigtail catheter. An emergency
echocardiography revealed the LVFWR (Fig. 1A and B) and an
emergency operation was indicated.
After induction of general anaesthesia, an intra-aortic balloon
pump (IABP) was placed via the right femoral artery to stabilize
the patient’s haemodynamics and to reduce the LV wall stress.
Following median sternotomy and opening of the pericardium, a
large clot was removed from the pericardial space. The heart was
elevated for inspection using a modiﬁed ‘Lima’ pericardial traction
stitch without the use of cardiopulmonary bypass. A region with
an epicardial haematoma was identiﬁed in the inferolateral wall,
and a small tear with visible ventricular muscle ﬁbres was found in
the infarcted area (Fig. 2A). One sheet (7 × 10 cm) of a xenogeneic
ECM membrane (CorMatrix ECM®, CorMatrix Cardiovascular, Inc.,
Atlanta, GA, USA) was trimmed and sutured with a running poly-
propylene 4-0 suture around the infarcted area covering the LV
rupture and creating a pouch (Fig. 2B). For reinforcement, the
created pouch was ﬁlled with 5 ml gelatine–resorcinol–formalde-
hyde glue (GRF® glue; Cardial-Bard, Sainte-Etienne, France) (Fig. 2C
and D). Additionally, a saphenous vein segment was grafted to the
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posterior descending artery. After placement of drainage tubes, the
chest was closed in standard fashion and the IABP was left in place
until the second postoperative day for afterload reduction and
consequently reducing the wall stress on the patched area.
The patient recovered very well from the operation, was easily
weaned from IABP and extubated on the third postoperative day.
The postoperative course was then complicated by the perforation
of a sigmoid colon diverticuli requiring a resection of the sigmoid
colon via median laparotomy.
The early postprocedural transoesophageal echocardiography
in the operating room showed a good result with normal LV size
and an LVEF of 45% with inferoseptal akinesia (Fig. 1C, Video 1).
The follow-up transthoracic echocardiography during his un-
eventful postoperative period and three months after operation
demonstrated an excellent result with normal LV size and an LVEF
of 50% with inferolateral and septal hypo-/akinesia (Fig. 1D, Video 2).
DISCUSSION
Several techniques for surgical treatment of acute or subacute
LVFWR have been described using a sutured or sutureless patch
with different currently available materials [1–3]. Which technique
and especially which material should be used are still not estab-
lished. The most frequently used patches are made from autolo-
gous pericardium or xenopericardium; however, they generally
undergo calciﬁcation and degradation in the long term. Other
options are synthetic materials like Dacron or expanded polytetra-
ﬂuoroethylene. These materials are not biocompatible and their
low pliability may be of technical disadvantage, especially in the
beating-heart technique.
An acellular porcine small intestinal submucosa-derived ECM
has been successfully introduced to surgery as a new substitute
material for different applications in order to sustain biocompati-
bility and potentially bioactivity, remodelling and even tissue
regeneration. The tissue remodelling and regeneration of this ma-
terial has been demonstrated in preclinical experiments [4].
Recently, this material has also successfully been introduced for
structural reconstruction in cardiac surgery [5]. Histological exam-
ination of explanted ECM patches showed resorption and no cal-
ciﬁcation of the material as well as replacement with organized
collagen and re-endothelialization [5].
This report demonstrates the acellular xenogeneic ECM
membrane as a convenient alternative material to synthetic or
Figure 1: (A) Preoperative transoesophageal echocardiogram (transgastric long-axis view) showing an inferolateral left ventricular free wall rupture with a cavity
created in the myocardium (white arrow) and an intrapericardial haematoma due to the lesion (asterisks). (B) Preoperative transoesophageal echocardiogram (trans-
gastric long-axis view) with colour Doppler demonstrating the created rupture cavity in the myocardium washed by the blood stream. (C) Immediate postoperative
transoesophageal echocardiogram (transgastric long-axis view) showing the inferolateral left ventricular free wall with the former myocardial cavity ﬁlled with GRF®
glue and covered by epicardial CorMatrix ECM® patch (white arrow). (D) Three-month postoperative transthoracic echocardiogram (apical two-chamber view)
showing the former inferolateral left ventricular free wall rupture with no more evidence of GRF® glue and epicardial CorMatrix ECM® patch. The hyperdense area is
representing scarring/remodelling myocardial tissue (white arrow). GRF® glue: gelatine–resorcinol–formaldehyde glue; ECM: extracellular matrix.
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pericardial substitute materials for the epicardial patch technique
to treat LVFWR, even when performed with an off-pump beating-
heart technique. Compared with conventional pericardial
patches, the advantage of this material is its excellent pliability
and therefore resulting in a lesser risk of tearing of the myocar-
dium as well as very easy stitching owing to the thinness of
Figure 2: (A) Intraoperative image showing a rupture of the inferior left ventricular free wall (arrow) in the distal region of the circumﬂex artery. (B) The CorMatrix
ECM® patch is sutured with a running polypropylene suture by the off-pump technique on the inferior left ventricular wall, creating a pouch. (C) The created pouch is
ﬁlled with GRF® glue to reinforce the sutured patch over the ruptured left ventricular free wall. (D) The ﬁnal image of the reinforced CorMatrix ECM® patch sutured on
the inferior left ventricular free wall. GRF® glue: gelatine–resorcinol–formaldehyde glue; ECM: extracellular matrix.
Video 1: Immediate postoperative transoesophageal echocardiogram (trans-
gastric long-axis view) showing normal left ventricular (LV) size and LV EF of
45% with inferolateral akinesia in the area of the former myocardial cavity ﬁlled
with GRF® glue and covered by epicardial CorMatrix ECM® patch. GRF® glue:
gelatine–resorcinol–formaldehyde glue; ECM: extracellular matrix.
Video 2: Three-month postoperative transthoracic echocardiogram (apical
two-chamber view) demonstrating normal LV size and LV EF of 50% with in-
ferolateral hypo-/akinesia in the area of the former LV free wall rupture. The
hyperdensity area represents a scarring/remodelling myocardial tissue with no
evidence of GRF® glue and the epicardial CorMatrix ECM® patch. GRF® glue:
gelatine–resorcinol–formaldehyde glue; ECM: extracellular matrix.
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the material. Bleeding prevention seems easier with this material
because the margins of the patches adapt much better than
bovine pericardium does. Despite its thinness, the patch is
highly tear-proof. The combination of suturing the CorMatrix
ECM® patch to the epicardium and additional use of a sealant
seems to be a very good option especially for haemostasis;
however, a sutureless direct gluing of this patch might also be an
option.
At follow-up, the LVEF increased when compared with the early
postoperative period, suggesting possible tissue regeneration. The
potential bioactivity and remodelling or even tissue regeneration of
the material in this clinical application have to be proven by longer-
term results.
Conﬂict of interest: none declared.
REFERENCES
[1] Padro JM, Mesa JM, Silvestre J, Larrea JL, Caralps JM, Cerron F et al.
Subacute cardiac rupture: repair with a sutureless technique. Ann Thorac
Surg 1993;55:20–3; discussion 23–4.
[2] Sakaguchi G, Komiya T, Tamura N, Kobayashi T. Surgical treatment for postin-
farction left ventricular free wall rupture. Ann Thorac Surg 2008;85:1344–6.
[3] Canovas SJ, Lim E, Hornero F, Montero J. Surgery for left ventricular free
wall rupture: patch glue repair without extracorporeal circulation. Eur J
Cardiothorac Surg 2003;23:639–41.
[4] Padalino MA, Castellani C, Dedja A, Fedrigo M, Vida VL, Thiene G et al.
Extracellular matrix graft for vascular reconstructive surgery: evidence of
autologous regeneration of the neoaorta in a murine model. Eur J
Cardiothorac Surg 2012;42:e128–35.
[5] Scholl FG, Boucek MM, Chan KC, Valdes-Cruz L, Perryman R. Preliminary
experience with cardiac reconstruction using decellularized porcine extra-
cellular matrix scaffold: human applications in congenital heart disease.
World J Pediatr Congenit Heart Surg 2010;1:132–6.
C
A
SE
R
EP
O
R
T
T. Holubec et al. / European Journal of Cardio-Thoracic Surgery 803
